These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29067995)

  • 1. Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime-boost immunization.
    Tan HX; Wheatley AK; Esterbauer R; Jegaskanda S; Glass JJ; Masopust D; De Rose R; Kent SJ
    Mucosal Immunol; 2018 May; 11(3):994-1007. PubMed ID: 29067995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.
    Çuburu N; Graham BS; Buck CB; Kines RC; Pang YY; Day PM; Lowy DR; Schiller JT
    J Clin Invest; 2012 Dec; 122(12):4606-20. PubMed ID: 23143305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge.
    Li Z; Zhang M; Zhou C; Zhao X; Iijima N; Frankel FR
    J Immunol; 2008 Feb; 180(4):2504-13. PubMed ID: 18250460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses.
    Tan HX; Gilbertson BP; Jegaskanda S; Alcantara S; Amarasena T; Stambas J; McAuley JL; Kent SJ; De Rose R
    Vaccine; 2016 Feb; 34(9):1172-9. PubMed ID: 26826545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systemic Prime-Intrarectal Pull Strategy Raises Rectum-Resident CD8+ T Cells for Effective Protection in a Murine Model of LM-OVA Infection.
    He Q; Jiang L; Cao K; Zhang L; Xie X; Zhang S; Ding X; He Y; Zhang M; Qiu T; Jin X; Zhao C; Zhang X; Xu J
    Front Immunol; 2020; 11():571248. PubMed ID: 33072113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
    Belyakov IM; Ahlers JD
    Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HIV-1-specific gastrointestinal tissue resident CD8
    Kiniry BE; Li S; Ganesh A; Hunt PW; Somsouk M; Skinner PJ; Deeks SG; Shacklett BL
    Mucosal Immunol; 2018 May; 11(3):909-920. PubMed ID: 29139476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
    Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
    J Virol; 2021 May; 95(12):. PubMed ID: 33789991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.
    Belyakov IM; Ahlers JD; Nabel GJ; Moss B; Berzofsky JA
    Virology; 2008 Nov; 381(1):106-15. PubMed ID: 18793787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating memory CD8
    Behr FM; Beumer-Chuwonpad A; Kragten NAM; Wesselink TH; Stark R; van Gisbergen KPJM
    Eur J Immunol; 2021 Jan; 51(1):151-166. PubMed ID: 32762051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary HIV Vaccines: Tissue Resident T-Cells and Strategies to Prevent Mucosal Infection.
    Tan HX; Kent SJ; De Rose R
    Curr Top Med Chem; 2016; 16(10):1107-17. PubMed ID: 26324042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
    Tritel M; Stoddard AM; Flynn BJ; Darrah PA; Wu CY; Wille U; Shah JA; Huang Y; Xu L; Betts MR; Nabel GJ; Seder RA
    J Immunol; 2003 Sep; 171(5):2538-47. PubMed ID: 12928404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and mucosal infection program protective memory CD8 T cells in the vaginal mucosa.
    Suvas PK; Dech HM; Sambira F; Zeng J; Onami TM
    J Immunol; 2007 Dec; 179(12):8122-7. PubMed ID: 18056354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique IL-13Rα2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8(+) T-cell avidity and protective immunity.
    Ranasinghe C; Trivedi S; Stambas J; Jackson RJ
    Mucosal Immunol; 2013 Nov; 6(6):1068-80. PubMed ID: 23403475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
    Hopkins R; Bridgeman A; Bourne C; Mbewe-Mvula A; Sadoff JC; Both GW; Joseph J; Fulkerson J; Hanke T
    Eur J Immunol; 2011 Dec; 41(12):3542-52. PubMed ID: 21932450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells.
    Haddadi S; Vaseghi-Shanjani M; Yao Y; Afkhami S; D'Agostino MR; Zganiacz A; Jeyanathan M; Xing Z
    Front Immunol; 2019; 10():2075. PubMed ID: 31552032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
    Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
    J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage form.
    Pattani A; McKay PF; Curran RM; McCaffrey J; Gupta PN; Lowry D; Kett VL; Shattock RJ; McCarthy HO; Malcolm RK
    Vaccine; 2012 Apr; 30(17):2778-85. PubMed ID: 22361120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunity.
    Maeto C; Rodríguez AM; Holgado MP; Falivene J; Gherardi MM
    PLoS One; 2014; 9(9):e107524. PubMed ID: 25215887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88.
    Zhang X; Dervillez X; Chentoufi AA; Badakhshan T; Bettahi I; Benmohamed L
    J Immunol; 2012 Nov; 189(9):4496-509. PubMed ID: 23018456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.